PELNSEPiramal Enterprises Limited· PharmaceuticalsMediumNeutral
Announced Tue, 6 May · 20:08 IST

Piramal Enterprises Limited has informed the Exchange about Appointment of Secretarial Auditor

Management Changes View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Enterprises' board, at its 6th May 2025 meeting, approved multiple governance items subject to shareholder approval. Three Independent Directors — Suhail Nathani, Anjali Bansal, and Kunal Bahl — were re-appointed for a second 5-year term starting October/November 2025. Chairman Ajay Piramal was allowed to continue as Whole-time Director beyond his 70th birthday (3rd August 2025) until the expiry of his current term on 31st March 2027. New joint statutory auditors N. M. Raiji & Co. and Chhajed & Doshi were appointed for 3 years (till the 81st AGM in 2028), replacing Suresh Surana & Associates and Bagaria & Co who complete their term at the 78th AGM. N. L. Bhatia & Associates was appointed as Secretarial Auditor for 5 years (till 2030).

Likely market impact

This is routine corporate housekeeping — a planned auditor rotation, standard independent director re-appointments, and continuation of the promoter Chairman. No governance red flags or sudden exits; unlikely to cause any meaningful share price movement.